Magpale, Rodelyn O.

HRN: 22-81-61  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/01/2023
CEFUROXIME 1.5GM (VIAL)
04/01/2023
04/07/2023
IV
1.5G
Q8h
UTI
04/05/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/05/2023
04/11/2023
IV
500mg
Q8h
Ameobiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: